Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Clinical Trials to Reduce the Risk of Antimicrobial Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial update on reducing antimicrobial resistance in bacterial pneumonia, terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Bacterial Pneumonia | Phase 2 | Status: TERMINATED | Results posted: 2017-04-20